-
Clinical UpdatesDrug News
Oct 28, 10 Drug NewsBritish pharmaceutical company GlaxoSmithKline will pay $750 million to settle allegations that it knowingly manufactured and sold adulterated drugs, including… »
Oct 28, 10 Drug NewsTeens should get a booster dose of the vaccine for bacterial meningitis because a single shot doesn’t work as long… »
Oct 27, 10 Drug NewsA new double-strain polio vaccine is more effective than triple and single vaccines and will be a potent weapon in… »
Oct 26, 10 Drug NewsSwitzerland’s innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime… »
Oct 26, 10 Drug NewsA popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.
Researchers… »
Oct 26, 10 Drug NewsGlaxoSmithKline has cut the price of its cervical cancer vaccine Cervarix by 30 percent in Canada in a bid to… »
Oct 24, 10 Drug NewsPatients admitted to the hospital for the common bacterial skin infection cellulitis should be treated as a first line of… »
Oct 22, 10 Drug NewsDoctors tend to prescribe drugs that pharmaceutical companies promote to them and patients end up paying more but not always… »
Oct 20, 10 Drug NewsMore than 17,000 doctors and other healthcare providers have taken money from seven major drug companies to talk to other… »
Oct 20, 10 Drug NewsA moldy odor has again stricken Johnson & Johnson’s Tylenol, and the company is recalling another lot of the… »
Oct 18, 10 Drug NewsAn American charity is offering to pay British drug or alcohol addicts 200 pounds ($320) to be sterilised - and… »
Oct 18, 10 Drug NewsA new study hints that higher Medicaid reimbursement rates could help get more poor kids vaccinated against the flu.
Although… »
Oct 12, 10 Drug NewsA mobile outreach program staffed by current and former sex workers is associated with increased entry to detoxification and residential… »
Oct 10, 10 Drug NewsAbbott Laboratories’ has pulled its controversial diet drug, Meridia, off the U.S. market after regulators said it was too dangerous,… »
Oct 10, 10 Drug NewsSwiss drugmaker Novartis AG said the average annual cost of its oral multiple sclerosis drug Gilenya will be $48,000 in… »
Subscribe to the "News" RSS Feed
TOP ۞